Innovative Drug Delivery Orbis Biosciences specializes in controlled-release technologies that enhance drug efficacy and patient adherence, presenting opportunities to collaborate with pharmaceutical companies seeking advanced delivery solutions to differentiate their therapeutic offerings.

Strategic Acquisitions Having been acquired by Adare Pharma Solutions, Orbis now benefits from expanded manufacturing capabilities and industry reach, enabling potential joint ventures or licensing deals with companies interested in next-generation pharmaceutical manufacturing technologies.

Active Collaborations Partnerships with notable players like Reckitt Benckiser and Daré Bioscience demonstrate Orbis’s capability to innovate in consumer healthcare and long-acting contraceptives, providing avenues to target clients across pharma and consumer healthcare sectors.

Recognition & Innovation Being recognized as a finalist in the FierceBiotech and FiercePharma Innovation Awards highlights Orbis’s potential as a leading innovator in drug delivery platforms, making it attractive for companies looking to enhance their product pipelines with cutting-edge technologies.

Market Focus & Growth With a focus on pharmaceutical and biotech collaborations and a global license agreement for consumer health products, Orbis offers sales opportunities in emerging markets where controlled-release technologies can address unmet needs and improve therapeutic outcomes.